Gujarat Exclusive >

Serum Institute

Update: Fire in Serum Institute premises in Pune kills 5

In an unfortunate development, five people lost their lives in the fire that broke out at Pune’s Serum Institute of India. Notably, the deceased were reportedly working in the under-construction building in SII premises where the fire broke at around 2.45 pm. The news was broke by SII chief Adar Poonawalla. He said, “We have...

Massive fire in Serum Institute premises, vaccines safe

A massive fire broke out at around 2.45 pm at a plant owned by the Serum Institute of India (SII) in Pune’s Manjri area. Apart from 10 fire engines, a team of the National Disaster Response Force is at the site to douse the flames. The unfortunate incident took place at an under-construction building at...

Pfizer, others will have to conduct clinical trials of COVID-19 vaccine in India for approval

Pfizer and BioNTech will have to conduct local clinical trials for securing emergency use authorisation for its COVID-19 vaccine, the government has said. The head of the government task force on COVID-19 vaccine, Dr. VK Paul, said that local clinical trials are a pre-condition for seeking emergency use authorisation. Notably, Pfizer and BioNTech have applied...

SII chief wants govt to indemnify vaccine manufacturers from lawsuits during pandemic

Serum Institute of India (SII) chief Adar Poonawalla has requested the Union government to indemnify it against litigations related to their vaccines, especially during a pandemic. He said vaccine manufacturers need to have protections against lawsuits and that they are going to propose the same to the government. Poonawalla said this while speaking at a...

DCGI seeks more data from Serum Institute, Bharat Biotech for approving their COVID vaccines

The government regulator dealing with the emergency use authorisation (EUA) application of COVID-19 vaccine manufacturers has clarified that the Serum Institute of India and Bharat Biotech will have to submit more data for securing EUA in India. The Subject Experts Committee (SEC) on EUA is of the view that it is better to wait for...

Controversy erupts over AstraZeneca’s COVID-19 vaccine efficacy claim

At a time when the low-cost COVID-19 vaccine candidate jointly developed by AstraZeneca and Oxford University seems to raise hopes for many countries including India, experts have raised questions on the manner in which the company arrived at the efficacy percentage for its vaccine candidate. The questions were raised after AstraZeneca and Oxford University acknowledged...

PM Modi likely to visit Serum Institute on Saturday

Prime Minister Narendra Modi is likely to visit the Serum Institute of India (SII), one of the world’s largest vaccine manufacturers, in Pune on Saturday. Notably, SII has joined hands with AstraZeneca and the University of Oxford for the mass-production of their vaccine candidate. The Union government has granted permission to seven firms for manufacture...

7 Indian pharma companies working on COVID-19 vaccine

At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally. Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are...